Works matching IS 13982273 AND DT 2016 AND VI 18 AND IP 3

Results: 24

Issue Information.

Published in:: Transplant Infectious Disease, 2016, v. 18, n. 3, p. 315, doi. 10.1111/tid.12439
Publication type:: Article

Heart transplantation and Candida endocarditis.

Published in:

Transplant Infectious Disease, 2016, v. 18, n. 3, p. 483, doi. 10.1111/tid.12520

By:

Checchia, T.E.;
Moura, L.Z.;
Colatusso, C.;
Veiga, S.;
Fortes, J.A.;
Tuon, F.F.

Publication type:

Article

Risk factors of asymptomatic shedding of enteric pathogens in renal transplant recipients.

Published in:

Transplant Infectious Disease, 2016, v. 18, n. 3, p. 480, doi. 10.1111/tid.12521

By:

Schvartz, B.;
Garcia, M.;
Wolak‐Thierry, A.;
De Champs, C.;
Leveque, N.

Publication type:

Article

Severe cryptococcal-associated neurological immune reconstitution inflammatory syndrome in a renal transplant recipient treated with adalimumab.

Published in:

Transplant Infectious Disease, 2016, v. 18, n. 3, p. 461, doi. 10.1111/tid.12522

By:

Deshayes, S.;
Bouvier, N.;
Chatelet, V.;
Hurault de Ligny, B.;
Dargère, S.;
Bonhomme, J.;
Béchade, C.

Publication type:

Article

A single-center experience with infections due to daptomycin-nonsusceptible Enterococcus faecium in liver transplant recipients.

Published in:

Transplant Infectious Disease, 2016, v. 18, n. 3, p. 341, doi. 10.1111/tid.12523

By:

Lewis, J.D.;
Enfield, K.B.;
Cox, H.L.;
Mathers, A.J.;
Sifri, C.D.

Publication type:

Article

Efficacy and safety of sofosbuvir/ledipasvir for the treatment of patients with hepatitis C virus re-infection after liver transplantation.

Published in:

Transplant Infectious Disease, 2016, v. 18, n. 3, p. 326, doi. 10.1111/tid.12524

By:

Ciesek, S.;
Proske, V.;
Otto, B.;
Pischke, S.;
Costa, R.;
Lüthgehetmann, M.;
Polywka, S.;
Klempnauer, J.;
Nashan, B.;
Manns, M.P.;
Hahn, T.;
Lohse, A.W.;
Wedemeyer, H.;
Mix, H.;
Sterneck, M.

Publication type:

Article

Efficacy and safety of tenofovir, entecavir, and telbivudine for chronic hepatitis B in heart transplant recipients.

Published in:

Transplant Infectious Disease, 2016, v. 18, n. 3, p. 319, doi. 10.1111/tid.12525

By:

Durante‐Mangoni, E.;
Vitrone, M.;
Parrella, A.;
Andini, R.;
Iossa, D.;
Ragone, E.;
Falco, E.;
Maiello, C.;
Utili, R.;
Zampino, R.

Publication type:

Article

Early non-invasive selection of patients at high risk of severe hepatitis C recurrence after liver transplantation.

Published in:

Transplant Infectious Disease, 2016, v. 18, n. 3, p. 471, doi. 10.1111/tid.12526

By:

Crespo, G.;
Gambato, M.;
Millán, O.;
Casals, G.;
Ruiz, P.;
Londoño, M.C.;
Mira, A.;
Forns, X.;
Brunet, M.;
Jiménez, W.;
Navasa, M.

Publication type:

Article

Diagnostic performance of 1,3-beta-D-glucan serum screening in patients receiving hematopoietic stem cell transplantation.

Published in:

Transplant Infectious Disease, 2016, v. 18, n. 3, p. 466, doi. 10.1111/tid.12527

By:

Reischies, F.M.J.;
Prattes, J.;
Woelfler, A.;
Eigl, S.;
Hoenigl, M.

Publication type:

Article

Children post liver transplantation hospitalized with fever are at a high risk for bacterial infections.

Published in:

Transplant Infectious Disease, 2016, v. 18, n. 3, p. 333, doi. 10.1111/tid.12528

By:

Ashkenazi‐Hoffnung, L.;
Mozer‐Glassberg, Y.;
Bilavsky, E.;
Yassin, R.;
Shamir, R.;
Amir, J.

Publication type:

Article

Anti- Aspergillus immunoglobulin-G testing in serum of hematopoietic stem cell transplant recipients.

Published in:

Transplant Infectious Disease, 2016, v. 18, n. 3, p. 354, doi. 10.1111/tid.12529

By:

Erdmann, J.‐H.;
Graf, B.;
Blau, I.W.;
Fischer, F.;
Timm, G.;
Hemmati, P.;
Arnold, R.;
Penack, O.

Publication type:

Article

Reconstitution of cytomegalovirus-specific T-cell response in allogeneic hematopoietic stem cell recipients: the contribution of six frequently recognized, virus-encoded ORFs.

Published in:

Transplant Infectious Disease, 2016, v. 18, n. 3, p. 381, doi. 10.1111/tid.12540

By:

Nemeckova, S.;
Krystofova, J.;
Babiarova, K.;
Hainz, P.;
Musil, J.;
Sroller, V.;
Maly, M.;
Stastna‐Markova, M.

Publication type:

Article

Detection of Epstein-Barr virus DNAemia after lung transplantation and its potential relationship with the development of post-transplant complications.

Published in:

Transplant Infectious Disease, 2016, v. 18, n. 3, p. 431, doi. 10.1111/tid.12541

By:

Silva, J.T.;
López‐Medrano, F.;
Alonso‐Moralejo, R.;
Fernández‐Ruiz, M.;
Pablo‐Gafas, A.;
Pérez‐González, V.;
San‐Juan, R.;
Pérez‐Jacoiste Asín, M.A.;
Ruiz‐Merlo, T.;
Folgueira, M.D.;
Aguado, J.M.

Publication type:

Article

Cytomegalovirus pre-emptive therapy after hematopoietic stem cell transplantation in the era of real-time quantitative PCR: comparison with recipients of solid organ transplants.

Published in:

Transplant Infectious Disease, 2016, v. 18, n. 3, p. 405, doi. 10.1111/tid.12542

By:

Panagou, E.;
Zakout, G.;
Keshani, J.;
Smith, C.;
Irish, D.;
Mackinnon, S.;
Kottaridis, P.;
Fielding, A.;
Griffiths, P.D.

Publication type:

Article

In kidney transplant recipients with BK polyomavirus infection, early BK nephropathy, microvascular inflammation, and serum creatinine are risk factors for graft loss.

Published in:

Transplant Infectious Disease, 2016, v. 18, n. 3, p. 361, doi. 10.1111/tid.12530

By:

Mohamed, M.;
Parajuli, S.;
Muth, B.;
Astor, B.C.;
Panzer, S.E.;
Mandelbrot, D.;
Zhong, W.;
Djamali, A.

Publication type:

Article

Sensitivity of blood and tissue diagnostics for gastrointestinal cytomegalovirus disease in solid organ transplant recipients.

Published in:

Transplant Infectious Disease, 2016, v. 18, n. 3, p. 372, doi. 10.1111/tid.12531

By:

Fisher, C.E.;
Alexander, J.;
Bhattacharya, R.;
Rakita, R.M.;
Kirby, K.A.;
Boeckh, M.;
Limaye, A.P.

Publication type:

Article

Failure of primary atovaquone prophylaxis for prevention of toxoplasmosis in hematopoietic cell transplant recipients.

Published in:

Transplant Infectious Disease, 2016, v. 18, n. 3, p. 446, doi. 10.1111/tid.12532

By:

Gajurel, K.;
Gomez, C.A.;
Dhakal, R.;
Vogel, H.;
Montoya, J.G.

Publication type:

Article

Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.

Published in:

Transplant Infectious Disease, 2016, v. 18, n. 3, p. 423, doi. 10.1111/tid.12533

By:

Hosseini‐Moghaddam, S.M.;
Alhomayeed, B.;
Soliman, N.;
Weir, M.A.;
House, A.A.

Publication type:

Article

Pre-transplant end-stage renal disease-related immune risk profile in kidney transplant recipients predicts post-transplant infections.

Published in:

Transplant Infectious Disease, 2016, v. 18, n. 3, p. 415, doi. 10.1111/tid.12534

By:

Crepin, T.;
Gaiffe, E.;
Courivaud, C.;
Roubiou, C.;
Laheurte, C.;
Moulin, B.;
Frimat, L.;
Rieu, P.;
Mousson, C.;
Durrbach, A.;
Heng, A.‐E.;
Saas, P.;
Bamoulid, J.;
Ducloux, D.

Publication type:

Article

Late sequelae of left ventricular assist device infection presenting after heart transplant.

Published in:

Transplant Infectious Disease, 2016, v. 18, n. 3, p. 453, doi. 10.1111/tid.12535

By:

Dulanto Chiang, A.;
Narsana, N.;
Ruiz, M.E.

Publication type:

Article

A potential role for cytomegalovirus in a facial ulcer in a renal transplant recipient.

Published in:

Transplant Infectious Disease, 2016, v. 18, n. 3, p. 457, doi. 10.1111/tid.12536

By:

Ezzatzadegan Jahromi, S.;
Lotfi, Z.;
Torabi‐Nezhad, S.;
Aslani, F.S.;
Pourabbas, B.

Publication type:

Article

Ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients: a single-center retrospective cohort study.

Published in:

Transplant Infectious Disease, 2016, v. 18, n. 3, p. 390, doi. 10.1111/tid.12537

By:

Young, P.G.;
Rubin, J.;
Angarone, M.;
Flaherty, J.;
Penugonda, S.;
Stosor, V.;
Ison, M.G.

Publication type:

Article

Removal from liver transplantation list of a hepatitis C virus- HIV co-infected patient after successful treatment with sofosbuvir and daclatasvir.

Published in:

Transplant Infectious Disease, 2016, v. 18, n. 3, p. 442, doi. 10.1111/tid.12538

By:

Llaneras, J.;
Castells, L.;
Santos, B.;
Crespo, M.;
Puig, T.;
Esteban, J.I.;
Esteban, R.

Publication type:

Article

Half-dose ganciclovir preemptive treatment of cytomegalovirus infection after pediatric allogeneic hematopoietic stem cell transplantation.

Published in:

Transplant Infectious Disease, 2016, v. 18, n. 3, p. 396, doi. 10.1111/tid.12539

By:

Ju, H.Y.;
Kang, H.J.;
Hong, C.R.;
Lee, J.W.;
Kim, H.;
Park, K.D.;
Shin, H.Y.;
Park, J.D.;
Choi, E.H.;
Lee, H.J.;
Ahn, H.S.

Publication type:

Article